» Articles » PMID: 36800999

Spatial Profiling Technologies Illuminate the Tumor Microenvironment

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2023 Feb 21
PMID 36800999
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor microenvironment (TME) is composed of many different cellular and acellular components that together drive tumor growth, invasion, metastasis, and response to therapies. Increasing realization of the significance of the TME in cancer biology has shifted cancer research from a cancer-centric model to one that considers the TME as a whole. Recent technological advancements in spatial profiling methodologies provide a systematic view and illuminate the physical localization of the components of the TME. In this review, we provide an overview of major spatial profiling technologies. We present the types of information that can be extracted from these data and describe their applications, findings and challenges in cancer research. Finally, we provide a future perspective of how spatial profiling could be integrated into cancer research to improve patient diagnosis, prognosis, stratification to treatment and development of novel therapeutics.

Citing Articles

Spatial immune scoring system predicts hepatocellular carcinoma recurrence.

Jia G, He P, Dai T, Goh D, Wang J, Sun M Nature. 2025; .

PMID: 40074893 DOI: 10.1038/s41586-025-08668-x.


Quantifying and interpreting biologically meaningful spatial signatures within tumor microenvironments.

Jing S, Wang H, Lin P, Yuan J, Tang Z, Li H NPJ Precis Oncol. 2025; 9(1):68.

PMID: 40069556 PMC: 11897387. DOI: 10.1038/s41698-025-00857-1.


Application of Spatial Omics in the Cardiovascular System.

Hu Y, Jia H, Cui H, Song J Research (Wash D C). 2025; 8:0628.

PMID: 40062231 PMC: 11889335. DOI: 10.34133/research.0628.


Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response.

Song J, Wei R, Liu C, Zhao Z, Liu X, Wang Y Nat Commun. 2025; 16(1):2175.

PMID: 40038297 PMC: 11880398. DOI: 10.1038/s41467-025-57465-7.


Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies.

Yang J, Zhou F, Luo X, Fang Y, Wang X, Liu X Cell Death Discov. 2025; 11(1):84.

PMID: 40032852 PMC: 11876437. DOI: 10.1038/s41420-025-02366-3.